Local intravenous therapy in chronic inflammatory and vascular disorders of the foot

International Surgery

Volumn 82, Issue 2, 1997, Pages 175-181

  El Sherif El Sarky, M ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Diabetic foot; Foot ulcers; Pedal ischemia; Retrograde venous perfusion

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; HEPARIN; LIDOCAINE; PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DIABETIC FOOT; DIALYSATE; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOOT DISEASE; FOOT ULCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; LONG TERM CARE; MALE; PERFUSION; VASCULAR DISEASE; VASCULAR SURGERY;

ALPROSTADIL; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHRONIC DISEASE; DIABETIC FOOT; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; FOOT; FOOT ULCER; GENTAMICINS; HEPARIN; HUMANS; ISCHEMIA; LIDOCAINE; MALE; MICROCIRCULATION; MIDDLE AGED; REGIONAL BLOOD FLOW;

EID: 0030760205     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot: soft tissue and bone infection. Infect Dis North Am 1990;4:409.
2. Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan et al. Foot infections in diabetic patients: decision and cost-effectiveness analysis. JAMA 1995:273(9):712-720.
3. Beach KW, Geri RB, Bergelin OR, Martin DC, Vandenberghe N, Zaccardi M et al. Progression of lower extremity arterial occlusive disease in type II diabetes mellitus. Diabetes Care 1988;11:464-472.
4. Buhler-Singer S, Hiller D, Albrecht HP, Seidel C, Hornstein OP. Disturbances of cutaneous microcirculation in patients with diabetic legs: Additional parameters for a new therapeutic concept? Acta Dermatol Venereol 1994;74:250-256.
5. Acevedo A, Schoop W. Insufficiencio arterial de la pernas. Rev Med Chil 1988;116:646-650.
6. Partsch H, Jochmann W, Mostbeck A, Hirschl M. Nuclear medicine studies of tissue concentration and hemodynamic effects of retrograde intravenous pressure infusions. Wien Med Wochenschr 1993;143(7-8):172-176.
7. Acevedo A, Decinti E, Toledo L, Perez O. Malum perforans diabeticorum: treatment with controlled circulatory blockade and regional intravenous administration of antibiotics. Wien Med Wochenschr 1993;143(7-8):195-198.
8. Seidel C, Buhler-Singer S, Tacke J, Hornstein OP. Therapeutic superiority of regional retrograde venous antibiotic pressure infusion versus systemic infusions in diabetic patients with infected neuropathic plantar ulcers. Hautarzt 1994;45(2):74-79.
9. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-723.
10. Seidel C, Richter UG, Buhler S, Hornstein OP. Drug therapy of diabetic neuropathic foot ulcers: transvenous retrograde perfusion versus systemic regimens. Vasa 1991;20(4):388-393.
11. Seidel C, Buhler-Singer S, Tacke J, Hornstein OP. Influx of antibiotics into diabetic legs with plantar ulcerations: regional and systemic Netilmycin levels compared after retrograde venous and systemic venous application. Vasa 1995;24(1):19-22.
12. Benton GS, Kernstein MD. Cost effectiveness of early digit amputation in the patient with diabetes. Surg Gynecol Obstet 1985; 161:523-524.
13. Hurlimann F. Intra-arterial treatment of peripheral circulatory disorders with trophic lesions. Praxis 1970;59:1435.
14. Malakar K, Sellwood RA. Effect of Solcoseryl on the survival of skin-grafts and healing of donor sites in rats. Br J Surg 1970; 57:221-222.
15. Kusztos D, Bereczky M, Ablonczy D, Lantos E, Landi W, Walton E et al. A controlled trial comparing two drugs used to treat peripheral vascular disorders with trophic lesions. Vasa 1972;212-214.
16. Niinikoski J, Renvall S. Effect of a deproteinized blood extract on experimental granulation tissue. Acta Chir Scand 1979;145:287.
17. Niinikoski J, Laato M, Tschannen R, Fraefel W. Effect of hexosylceramide fraction of the hemodialysate Solcoseryl on wound healing angiogenesis. Eur Surg Res Suppl 1984; 16/51/84:106-107.
18. Schreier T, Degen E, Baschong W. Fibroblast migration and proliferation during in vitro wound healing. A quantitative comparison between various growth factors and a low molecular weight blood dialysate used in the clinic to normalize impaired wound healing. Res Exp Med Berl 1993;193(4):195-205.
19. Horsch S, Diehm C, Rieger H, Cachovan M, Baitsch G, Claeys L. Clinical efficacy of deproteinized hemodialysate in the treatment of intermittent claudication. Int J Angiol 1994;2(4):167-172.
20. Smahel J. Effect of a protein-free hemodialysate on the recovery of blood circulation in an ischemic skin lesion. Br J Exp Pathol 1982;63:177-183.
21. Charlesworth D, Harris PL, Palmar MK. Intra-arterial infusion of Solcoseryl: a clinical trial of a method of treatment for pregangrene of the lower limb. Br J Surg 1975;62(5):337-339.
22. Pallapies D, Peskar BA. Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation. Thromb Res 1993;71(3):217-225.
23. Walpoth BH, Amonn A, Galdikas J, Ris HB, Schaffner T, Hoflin F, Schilt W, Mettler D, Nachnbur B, Althaus U. Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment. Eur J Vasc Surg 1993;7(5):493-499.
24. Diaz-Flores L, Gutierrez R, Valladares F, Varela H, Perez M. Intense vascular sprouting from rat femoral vein induced by prostaglandins E1 and E2. Anat Rec 1994;238(1):68-76.
25. Wang L, Wu J, Sun X. The effect of prostaglandin E1 on myocardial ischemia reperfusion injury. Chung Hua Nei Ko Tsa Chih 1995;34(2):98-101.
26. Vargas AV, Krishnamurthi V, Masih R, Robinson AV, Schulak JA. Prostaglandin E1 attenuation of ischemic renal reperfusion injury in the rat. J Am Coll Surg 1995;180(6):713-717.
27. Matsuzaki Y, Waddell TK, Puskas JD, Hirai T, Nakajima S, Slutsky AS, Patterson GA. Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1. Am Rev Respir Dis 1993;148(4 Pt 1):882-889.
28. Lin PJ, Hsieh MJ, Cheng KS, Kuo TT, Chang CH. University of Wisconsin solution extends lung preservation after prostaglandin E1 infusion. Chest 1994;105(1):255-261.
29. Kuroda T, Shiohara E, Haba Y, Hanazaki K, Homma T, Iwatsuki K, Chiba S. Prostaglandin E1 protects dog pancreas from ischemia-reperfusion injury. Pancreas 1994;9(3):354-360.
30. Sawada Y, Hatayama I, Sone K. The relationship between time of application of prostaglandin E1 and improved flap survival. Br J Plast Surg 1993;46(7):580-581.
31. 1 and urinastatin. Nippon Geka Gakkai Zasshi 1993;9 (3):259-268.
32. Kukita I, Goto T, Shibata Y, Baba T, Sakata R, Nakayama R, Morioka T. Protective effects of prostaglandin E1 on postoperative liver function after cardiac surgery. Masui 1994;43(6):898-904.
33. 1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg 1994;220(1):53-58.
34. Altstaedt HO, Berzewski B, Breddin HK, Brockhaus W, Bruhn HD, Cachovan M, Diehm C, Dorrler J, Franke CS, Gruss JD. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 1993;49(2):573-578.
35. Ciostek P, Kostewicz W, Gorski G. Results of intra-arterial administration of PGE1 prostaglandin. Wiad Lek 1994;47(19-20):750-752.
36. Occhionorelli S, Mascoli F, Vasquez G, Santini M, Navarra G, Carcoforo P, Donini I. Use of PGE1 in severe ischemia of the lower extremities. Clinical study. Minerva Cardioangiol 1995;43(6): 247-256.
37. Scheffler P, de la Hamette D, Gross J, Mueller H, Schieffer H. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxyfilline during training. Circulation 1994;90(2):818-822.
38. Kwan CM, Chang WC, Chen JH, Wang MY. The effect of intravenous infusion of prostaglandin E1 on cutaneous microcirculation in black foot disease. J Formos Med Assoc 1993; 92(7):603-608.
39. Chang CH, Yu HS, Chen GS, Wang MT, Ko SS. Study on black foot disease: with special reference to evaluating its cutaneous microcirculatory status. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1993;9(10):559-566.